Forte Biosciences Inc logo

Forte Biosciences Inc

Forte Biosciences Inc. is a clinical-stage biopharmaceutical company in the United States. The company focuses on the development of first-in-class oral drugs for cancer, inflammation and fibrosis. Its lead product candidate is a dual inhibitor of chitin synthesis and metalloproteinases (NanoFol14) for the treatment of solid tumors including lung cancer, pancreatic cancer, glioblastoma and other cancers. The company is also developing ubenimex (a CCR5 antagonist), which is used for HIV entry inhibition; and an anti-angiogenesis drug for treating pancreatic cancer and other indications.

Latest events on Quartr

Previous Events for Forte Biosciences Inc




United States of America

About the company

Investor Relations page

Dig deeper into the fundamentals using Quartr - Investor relations

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
Android play link
App store link
Quartr app screenshot